Table 5.
Discharge prescription rates of antiplatelet agents/anticoagulants, β-blockers, LLDs, and blockers of the renin-angiotensin system according to estimated CrC
| Medication Use | ≤45 ml/min (n = 144) | 45 to 60 ml/min (n = 192) | >60 ml/min (n = 722) | Differencea |
|---|---|---|---|---|
| Aspirin (%) | 123 (85) | 175 (91) | 678 (94) | −9 (−15, −3)b |
| Any antiplatelet agent (%) | 130 (90) | 179 (93) | 705 (98) | −8 (−13, −3)b |
| Warfarin (%) | 28 (19) | 23 (12) | 57 (8) | 11 (4, 18)b |
| Any antiplatelet agent/warfarin (%) | 143 (99) | 189 (98) | 719 (100) | −1 (−3, 1) |
| β-blockers (%) | 107 (74) | 160 (83) | 599 (83) | −9 (−17, −1)b |
| LLDs (%) | 105 (73) | 140 (73) | 579 (80) | −7 (−13, −1)b |
| ACE inhibitor/ARB (%) | 94 (65) | 122 (63) | 421 (58) | 7 (−1, 15) |
a
Reported differences are between subjects with a CrC ≤45 ml/min and the reference group (>60 ml/min) and are expressed in % with a 95% CI.
b
P ≤ 0.05 by χ2 for a difference between the three groups.